Discover investment opportunities in AI Healthcare Stocks To Buy using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in AI Healthcare Stocks To Buy using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in AI Healthcare Stocks To Buy using our Smart AI Filter.
9 stocks found for "AI Healthcare Stocks To Buy"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.24 | ±27.6% | 13.6 | 0.00% | |||
1.02 | ±54.4% | 38.7 | 0.03% | |||
0.64 | ±28.2% | 69.3 | 0.00% | |||
1.19 | ±53.7% | -156.9 | 0.00% | |||
1.77 | ±71.4% | -18.6 | 0.00% | |||
0.92 | ±51.9% | 41.3 | 0.00% | |||
1.50 | ±64.8% | -8.0 | 0.00% | |||
0.80 | ±35.4% | 77.8 | 0.00% | |||
1.02 | ±49.1% | 40.9 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: How has Teladoc Health Inc. (TDOC) performed during economic downturns?
A: Teladoc Health Inc. (TDOC) has historically shown resilience in economic downturns due to rising demand for telehealth services as patients and providers seek cost-effective healthcare solutions. However, market conditions and industry factors should be considered for thorough evaluation.
Q: What growth opportunities exist for Guardant Health Inc. (GH) in the liquid biopsy sector?
A: Guardant Health Inc. (GH) operates in the liquid biopsy market, which is projected to grow as personalized medicine advances. Their Guardant360 test has garnered attention for its potential to change cancer diagnostics, presenting growth opportunities.
Q: Is InVitae Corp. (NVTA) suitable for value investors?
A: InVitae Corp. (NVTA) may not be ideal for value investors focused on P/E ratios, as the company has historically not been profitable. Potential investors should consider the company's financial health and growth prospects in the genetic testing industry.
Q: What role does Dexcom Inc. (DXCM) play in diabetes management?
A: Dexcom Inc. (DXCM) specializes in continuous glucose monitoring systems for diabetes management. These devices are crucial for real-time glucose tracking, potentially improving patient outcomes and attracting interest in the growing diabetes care market.
Q: How does Intuitive Surgical Inc. (ISRG) maintain a competitive edge?
A: Intuitive Surgical Inc. (ISRG) maintains its competitive edge through its da Vinci Surgical System, which is widely adopted for minimally invasive procedures. Continuous innovation and a strong service model further bolster its market position.
Q: Are there risks associated with Cerus Corp. (CERS) and blood safety?
A: Cerus Corp. (CERS) focuses on blood safety technologies, which are subject to regulatory approval and adoption rates. Delays or setbacks in these areas could impact stock performance, highlighting the importance of regulatory and market conditions.